AbbVie Inc. [ABBV] stock was sold by GONZALEZ RICHARD A at the price of US$8.91 million


In a filing, AbbVie Inc. revealed its CHAIRMAN OF THE BOARD AND CEO GONZALEZ RICHARD A unloaded Company’s shares for reported $8.91 million on Aug 01. In the deal valued at $148.58 per share,60,000 shares were sold. As a result of this transaction, GONZALEZ RICHARD A now holds 565,294 shares worth roughly $ 82.59 million.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Then, GONZALEZ RICHARD A sold 18,500 shares, generating $2,759,275 in total proceeds. Upon selling the shares at $149.15, the CHAIRMAN OF THE BOARD AND CEO now owns 625,294 shares.

Before that, Sorg Elaine K. sold 6,130 shares. AbbVie Inc. shares valued at $1,011,450 were divested by the SVP, US COMMERCIAL OPERATIONS at a price of $165.00 per share. As a result of the transaction, Sorg Elaine K. now holds 35,330 shares, worth roughly $5.16 million.

William Blair initiated its AbbVie Inc. [ABBV] rating to a Mkt perform in a research note published on Tuesday.

Price Performance Review of ABBV

On Tuesday, AbbVie Inc. [NYSE:ABBV] saw its stock fall -1.42% to $146.10. On the same session, the stock had its day’s lowest price of $145.86, but rose to a high of $148.96. Over the last five days, the stock has lost -0.90%. AbbVie Inc. shares have fallen nearly -9.60% since the year began. Nevertheless, the stocks have risen 5.53% over the past one year. While a 52-week high of $168.11 was reached on 01/06/23, a 52-week low of $130.96 was recorded on 06/28/23. SMA at 50 days reached $143.75, while 200 days put it at $150.44. A total of 3.91 million shares were traded, compared to the trading of 3.36 million shares in the previous session.

Levels Of Support And Resistance For ABBV Stock

The 24-hour chart illustrates a support level at 144.99, which if violated will result in even more drops to 143.87. On the upside, there is a resistance level at 148.09. A further resistance level may holdings at 150.07. The Relative Strength Index (RSI) on the 14-day chart is 45.54, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.14, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 96.90%. Stochastics %K at 20.70% indicates the stock is a holding.

How much short interest is there in AbbVie Inc.?

A steep rise in short interest was recorded in AbbVie Inc. stocks on Aug 14, 2023, growing by 3.75 million shares to a total of 13.26 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 9.51 million shares. There was a rise of 28.28%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 0.75% of the overall stock float, the days-to-cover ratio (short ratio) rose to 2.53.

AbbVie Inc. [ABBV] – Who Are The Largest Shareholders?

In filings from The Vanguard Group, Inc., it is revealed that the company now owns 151,643,680 shares, or roughly 8.60% of the outstanding ABBV shares. In other words, the investor’s shares have fallen by -992,877 from its previous 13-F filing of 152636557.0. Additionally, BlackRock Fund Advisors increased 0.79% of its stake after which the total value it holdings stand at $13,711,629,586, while SSgA Funds Management, Inc. added 1.50% of its stake to hold $11.69 billion in the firm. Over the last quarter, Capital Research & Management Co purchased 404,379 shares of AbbVie Inc., while JPMorgan Investment Management, I bought -1,223,093 shares. At present, Geode Capital Management LLC is holding 34,952,938 shares valued at $5.23 billion. Capital Research & Management Co owned 32,545,522 shares of the company at the time of its most recent 13F filing, worth $4.87 billion.


Please enter your comment!
Please enter your name here